AstraZeneca to withdraw Covid vaccine globally, calls timing a coincidence: Report

1 week ago

Pharmaceutical giant AstraZenaca will withdraw the Covid-19 vaccine from markets globally, as the company points out the reason for the withdrawal as commercial reasons.

In India, the Vaxzevria vaccine of AstraZeneca was produced by Adar Poonawalla-led Serum Institute of India (SII) and marketed as Covishield.

The pharma giant said that the vaccine is being removed from the markets for commercial reasons.

India Today World Desk

New Delhi,UPDATED: May 8, 2024 03:06 IST

The pharmaceutical giant AstraZeneca's Covid-19 vaccine is being withdrawn globally after the company acknowledged in court documents that it can cause a rare and dangerous side effect. However, the pharma giant said that the vaccine is being removed from the markets for commercial reasons.

As the company voluntarily withdrew its "marketing authorisation", the vaccine is no longer authorised for use in the European Union. The withdrawal application was submitted on March 5 and took effect on Tuesday.

Similar withdrawal applications will be submitted in the UK and other countries that had previously approved the vaccine, known as Vaxzevria.

Calling the decision "purely coincidental", the pharma giant has insisted that the withdrawal of vaccine is not linked to its admission that it can cause TTS - Thrombosis Thrombocytopenia Syndrome.

Published By:

Vadapalli Nithin Kumar

Published On:

May 8, 2024

Tune In

Read Full Article at Source